NASDAQ: GALT       Galectin Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
2.26   -0.06 (2.59%)  2.22 - 2.35  157,496


Avg Volume (4 weeks):371,857
4 Weeks Range:1.92 - 2.67
4 Weeks Price Volatility (%):
52 Weeks Range:1.50 - 3.85
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2347  4078  313  3283 

Top 10 Active Counters
 SNDL 1.429+0.079 
 WPX 9.43+0.48 
 SOS 7.18+0.49 
 NIO 45.19-4.57 
 SNSS 5.32+1.04 
 RKT 29.40+5.10 
 AAPL 125.92-1.87 
 AMC 8.98-0.20 
 PE 16.93+0.52 
 CFMS 1.18+0.12